A board to discuss Tcelna as a treatment for Multiple Sclerosis
- Volunteer Moderator
- Posts: 5381
- Joined: Sat Nov 20, 2004 3:00 pm
As I had predicted almost a year ago
, on December 14th Opexa executed another reverse split. This time it was 1:4. Since then, their stock has fallen an additional 35.2% in value. This does not seem to put them in a good position for their ongoing trial of Tovaxin (Tcelna) with SPMS.
http://www.opexatherapeutics.com/121412 ... cle=121412